Skip to main content

Advertisement

Log in

Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development

  • Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Phosphodiesterases (PDEs) are essential regulators of cyclic nucleotide signaling with diverse physiological functions. Because of their great market potential and therapeutic importance, PDE inhibitors became recognized as important therapeutic agents in the treatment of various diseases. Currently, there are seven PDE inhibitors on the market, and the pharmacological and safety evaluations of many drug candidates are in progress. Three-dimensional (3D) structures of catalytic domains of PDE 1, -3, -4, -5 and -9 in the presence of their inhibitors are now available, and can be utilized for rational drug design. Recent advances in molecular pharmacology of PDE isoenzymes resulted in identification of new potential applications of PDE inhibitors in various therapeutic areas, including dementia, depression and schizophrenia. This review will describe the latest advances in PDE research on 3D structural studies, the potential of therapeutic applications and the development of drug candidates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. M. Cho.

Additional information

Received 30 November 2004; received after revision 24 January 2005; accepted 5 February 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeon, Y.H., Heo, Y.S., Kim, C.M. et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. CMLS, Cell. Mol. Life Sci. 62, 1198–1220 (2005). https://doi.org/10.1007/s00018-005-4533-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-005-4533-5

Key words.

Navigation